Promising effect of propolis and a by-product on planktonic cells and biofilm formation by the main agents of human fungal infections

• Autor(a) principal: BARROS,ISABELLA L.E.
• Data de Publicação: 2022
• Outros Autores: VEIGA,FLÁVIA F., JARROS,ISABELE C., CORRÊA,JAKELINE L., SANTOS,RAFAELA S. DOS, BRUSCHI,MARCOS L., NEGRI,MELYSSA, SVIDZINSKI,TEREZINHA I.E.
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Anais da Academia Brasileira de Ciências (Online)
• Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652022000300604
• topic: antifungal activity; new biological product; prevention; propolis reuse; treatment; waste products

Abstract Few antifungals available today are effective in treating biofilms. Thus, it is urgent to discover new compounds, such as natural products, that provide improvements to existing treatments or the development of new antifungal therapies. This study aimed to perform a comparative analysis between the green propolis extract (PE) and its by-product, a waste of propolis extract (WPE) through a screening with Candida sp., Fusarium sp. and Trichophyton sp. The antifungal property of PE and WPE was assessed by the minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) determination in planktonic cells. The influence of both extracts on the inhibition of biofilm formation in these fungi was also tested. The WPE MIC and MFC values (68.75 to 275.0 µg/mL) were three to twelve times lower than the values obtained for PE (214.06 to 1712.5 µg/mL). PE was more efficient than WPE in inhibiting the biofilm initial phase, especially in C. albicans. Meanwhile, WPE had dose-dependent behavior for the three fungi, being more effective on filamentous ones. Both PE and WPE showed excellent antifungal activity on planktonic cells and demonstrated great efficacy for inhibiting biofilm formation in the three fungi evaluated.